학술논문

Comparison of switching to 6-week dosing of natalizumab versus continuing with 4-week dosing in patients with relapsing-remitting multiple sclerosis (NOVA): a randomised, controlled, open-label, phase 3b trial
Document Type
Article
Author
van der Walt, AnnekeDwyer, ChristopherBuzzard, KatherineSpies, JudithParratt, Johnvan Pesch, VincentWillekens, BarbaraPerrotta, GaetanoBartholomé, EmmanuelGrand'Maison, FrancoisJacques, FrancoisGiacomini, PaulVosoughi, RezaGirard, Jean-Marcde Seze, JeromeLebrun Frenay, ChristineRuet, AurelieLaplaud, David-AxelReifschneider, GerdWagner, BertRauer, SebastianPul, RefikSeipelt, MariaBerthele, AchimKlotz, LuisaKallmann, Boris-AlexanderPaul, FriedemannAchiron, AnatLus, GiacomoCentonze, DiegoPatti, FrancescoGrimaldi, LuigiHupperts, RaymondFrequin, StephanFermont, JiskeMadueno, Sara EichauAlonso Torres, Ana MariaCosta-Frossard França, LucienneMeca-Lallana, Jose EustasioRuiz, Luis BrievaPearson, OwenRog, DavidEvangelou, NikolaosIsmail, AzzaLathi, EllenFox, EdwardLeist, ThomasSloane, JacobWu, GregoryKhatri, BhupendraSteingo, BrianThrower, BenGudesblatt, MarkCalkwood, JonathanBandari, DanielScagnelli, JohnLaganke, ChristopherRobertson, DerrickKipp, LucasBelkin, MartinCohan, StanleyGoldstick, LawrenceCourtney, ArdithVargas, WendySylvester, AndrewSrinivasan, JayshriKannan, MeenaPicone, MaryannEnglish, JeffreyNapoli, SalvatoreBalabanov, RoumenZaydan, IslamNicholas, JacquelineKaplan, JeffreyLublin, FredRiser, EmilyMiller, TamaraAlvarez, EnriqueWray, SibylGross, JeffreyPawate, SiddharamaHersh, CarrieMcCarthy, LucasCrayton, HeidiGraves, JenniferFoley, John FDefer, GillesRyerson, Lana ZhovtisCohen, Jeffrey AArnold, Douglas LButzkueven, HelmutCutter, GaryGiovannoni, GavinKillestein, JoepWiendl, HeinzSmirnakis, KarenXiao, ShanKong, GeorgeKuhelj, RobertCampbell, Nolan
Source
In The Lancet Neurology July 2022 21(7):608-619
Subject
Primary Research
Articles
Language
ISSN
1474-4422